HK1197176A1 - 含有瑞格非尼的局部眼用藥物組合物 - Google Patents

含有瑞格非尼的局部眼用藥物組合物

Info

Publication number
HK1197176A1
HK1197176A1 HK14110517A HK14110517A HK1197176A1 HK 1197176 A1 HK1197176 A1 HK 1197176A1 HK 14110517 A HK14110517 A HK 14110517A HK 14110517 A HK14110517 A HK 14110517A HK 1197176 A1 HK1197176 A1 HK 1197176A1
Authority
HK
Hong Kong
Prior art keywords
pharmaceutical composition
composition containing
ophthalmological pharmaceutical
topical ophthalmological
containing regorafenib
Prior art date
Application number
HK14110517A
Other languages
English (en)
Inventor
Michael Bttger
Degenfeld Georges Von
Julia Freundlieb
Claudia Hirth-Dietrich
Joerg Keldenich
Jrgen Klar
Uwe Muenster
Andreas Ohm
Annett Richter
Bernd Riedl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46456546&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1197176(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of HK1197176A1 publication Critical patent/HK1197176A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
HK14110517A 2011-06-28 2014-10-22 含有瑞格非尼的局部眼用藥物組合物 HK1197176A1 (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP11171719 2011-06-28
EP12155281 2012-02-14
PCT/EP2012/062365 WO2013000917A1 (en) 2011-06-28 2012-06-26 Topical ophthalmological pharmaceutical composition containing regorafenib

Publications (1)

Publication Number Publication Date
HK1197176A1 true HK1197176A1 (zh) 2015-01-09

Family

ID=46456546

Family Applications (1)

Application Number Title Priority Date Filing Date
HK14110517A HK1197176A1 (zh) 2011-06-28 2014-10-22 含有瑞格非尼的局部眼用藥物組合物

Country Status (25)

Country Link
US (1) US20140296301A1 (zh)
EP (1) EP2726059A1 (zh)
JP (1) JP5998213B2 (zh)
KR (1) KR20140048218A (zh)
CN (1) CN103889399A (zh)
AP (1) AP2013007335A0 (zh)
AR (1) AR086800A1 (zh)
AU (1) AU2012277905A1 (zh)
BR (1) BR112013033831A2 (zh)
CA (1) CA2840329A1 (zh)
CL (1) CL2013003700A1 (zh)
CO (1) CO6920289A2 (zh)
CR (1) CR20130693A (zh)
CU (1) CU24163B1 (zh)
DO (1) DOP2013000314A (zh)
EA (1) EA201400064A1 (zh)
EC (1) ECSP13013106A (zh)
GT (1) GT201300322A (zh)
HK (1) HK1197176A1 (zh)
MX (1) MX2013015287A (zh)
PE (1) PE20141031A1 (zh)
TN (1) TN2013000533A1 (zh)
UY (1) UY34166A (zh)
WO (1) WO2013000917A1 (zh)
ZA (1) ZA201400646B (zh)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20090018224A (ko) 2004-09-29 2009-02-19 바이엘 헬스케어 아게 열역학적으로 안정한 형태의 ｂａｙ 43-9006 토실레이트
AR081060A1 (es) 2010-04-15 2012-06-06 Bayer Schering Pharma Ag Procedimiento para preparar 4-{4-[({[4-cloro-3-(trifluorometil)fenil]amino}carbonil)amino]-3-fluorofenoxi}-n-metilpiridin-2-carboxamida
UY35183A (es) * 2012-12-21 2014-07-31 Bayer Healthcare Llc Composición farmacéutica oftalmológica tópica que contiene regorafenib
WO2015011659A1 (en) * 2013-07-24 2015-01-29 Dr. Reddys Laboratories Limited Crystalline polymorphic forms of regorafenib and processes for the preparation of polymorph i of regorafenib
CN103923000A (zh) * 2014-01-29 2014-07-16 苏州晶云药物科技有限公司 几种新晶型及其制备方法
CN104546776B (zh) * 2015-02-10 2017-08-22 杭州朱养心药业有限公司 瑞戈非尼片剂药物组合物和制法
KR20240043821A (ko) * 2015-06-06 2024-04-03 클라우드브레이크 테라퓨틱스, 엘엘씨 익상편을 치료하기 위한 조성물 및 방법
MX2018014868A (es) 2016-06-02 2019-09-13 Cloudbreak Therapeutics Llc Composiciones y metodos de uso de nintedanib para mejorar el exito de la cirugia del glaucoma.

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2732222B1 (fr) * 1995-03-28 1997-04-25 Oreal Utilisation d'un antagoniste de cgrp pour le traitement des prurits et des dysesthesies oculaires et palpebraux
NZ537308A (en) * 2002-05-28 2009-09-25 Nycomed Gmbh Ophthalmological use of roflumilast for the treatment of diseases of the eye
DE602004010407T2 (de) * 2003-07-23 2008-10-16 Bayer Pharmaceuticals Corp., West Haven Fluorsubstituierter omega-carboxyaryldiphenylharnstoff zur behandlung und prävention von krankheiten und leiden
DK1885336T3 (da) 2005-05-10 2009-05-25 Alcon Inc Suspensionsformuleringer, der omfatter et aktivt princip, et overfladeaktivt poloxamer- eller meroxapolmiddel og en glycol, samt deres anvendelse til fremstilling af et medikament til behandling af öjenlidelser
JP2008543775A (ja) 2005-06-08 2008-12-04 ターゲジェン インコーポレーティッド 眼の障害を治療するための方法および組成物
CA2631173A1 (en) 2005-11-29 2007-06-07 Smithkline Beecham Corporation Treatment method
WO2007068382A1 (en) * 2005-12-15 2007-06-21 Bayer Healthcare Ag Diaryl urea for treating inflammatory skin. eye and/or ear diseases
US20070149593A1 (en) 2005-12-23 2007-06-28 Alcon, Inc. PHARMACEUTICAL FORMULATION FOR DELIVERY OF RECEPTOR TYROSINE KINASE INHIBITING (RTKi) COMPOUNDS TO THE EYE
WO2008027341A2 (en) 2006-08-30 2008-03-06 Merck & Co., Inc. Topical ophthalmic formulations
AR062927A1 (es) * 2006-10-11 2008-12-17 Bayer Healthcare Ag 4- [4-( [ [ 4- cloro-3-( trifluorometil) fenil) carbamoil] amino] -3- fluorofenoxi) -n- metilpiridin-2- carboxamida monohidratada
CN101678006A (zh) * 2007-05-11 2010-03-24 参天制药株式会社 含有非麦角类的选择性d2受体激动剂作为有效成分的后眼部疾病的预防或治疗剂
DE102007055341A1 (de) * 2007-11-19 2009-05-20 Bayer Animal Health Gmbh Stabilisierung öliger Suspensionen enthaltend hydrophobe Kieselsäuren
WO2010127029A1 (en) 2009-05-01 2010-11-04 Ophthotech Corporation Methods for treating or preventing ophthalmological diseases
CN102573477A (zh) 2009-07-16 2012-07-11 葛兰素惠尔康制造业私人有限公司 治疗方法

Also Published As

Publication number Publication date
CO6920289A2 (es) 2014-04-10
CA2840329A1 (en) 2013-01-03
CU24163B1 (es) 2016-03-31
BR112013033831A2 (pt) 2017-02-14
AR086800A1 (es) 2014-01-22
AP2013007335A0 (en) 2013-12-31
TN2013000533A1 (en) 2015-03-30
JP2014518233A (ja) 2014-07-28
WO2013000917A1 (en) 2013-01-03
CL2013003700A1 (es) 2014-07-18
ECSP13013106A (es) 2014-01-31
JP5998213B2 (ja) 2016-09-28
GT201300322A (es) 2014-11-13
MX2013015287A (es) 2014-03-31
NZ619229A (en) 2016-04-29
CU20130168A7 (es) 2014-04-24
KR20140048218A (ko) 2014-04-23
ZA201400646B (en) 2015-11-25
UY34166A (es) 2013-01-31
EP2726059A1 (en) 2014-05-07
EA201400064A1 (ru) 2014-05-30
US20140296301A1 (en) 2014-10-02
CN103889399A (zh) 2014-06-25
PE20141031A1 (es) 2014-08-21
CR20130693A (es) 2016-05-02
AU2012277905A1 (en) 2014-01-16
DOP2013000314A (es) 2014-04-15
AU2012277905A8 (en) 2014-01-30

Similar Documents

Publication Publication Date Title
HK1214170A1 (zh) 含有瑞戈非尼的包衣的藥物組合物
AP3864A (en) Pharmaceutical composition
HK1204564A1 (zh) 含有阿昔替尼的局部眼科藥物組合物
HK1197176A1 (zh) 含有瑞格非尼的局部眼用藥物組合物
GB201118232D0 (en) Pharmaceutical composition
HK1204563A1 (zh) 含有帕唑帕尼的局部眼科藥物組合物
HK1204992A1 (zh) 含有舒尼替尼的局部眼科藥物組合物
EP2702989A4 (en) STABLE PHARMACEUTICAL COMPOSITION
HK1189158A1 (zh) 藥用組合物
EP2769718A4 (en) MEDICINAL COMPOSITION
HK1188791A1 (zh) 新型八氫噻吩並喹啉衍生物、包含所述衍生物的藥物組合物及它們的用途
EP2685993A4 (en) PHARMACEUTICAL COMPOSITIONS AND TOPICAL USE THEREOF
ZA201505196B (en) Topical ophthalmological pharmaceutical composition containing regorafenib
HK1204289A1 (zh) 含有西地尼布的局部眼科藥物組合物
EP2727593A4 (en) PHARMACEUTICAL COMPOSITION CONTAINING NICORANDIL
EP2711010A4 (en) PHARMACEUTICAL COMPOSITION
HUP1100444A2 (en) Pharmaceutical composition
EP2883546A4 (en) NOVEL DIFFERENTIALLY RELEASING PHARMACEUTICAL COMPOSITION CONTAINING THREE ACTIVE INGREDIENTS
EP2851074A4 (en) ANALGETIC PHARMACEUTICAL COMPOSITION
EP2727594A4 (en) NEW PHARMACEUTICAL COMPOSITION
HUP1100445A2 (en) Pharmaceutical composition
ZA201309537B (en) Pharmaceutical composition comprising fexofedine
AU2011905393A0 (en) Pharmaceutical Composition